ID: hyp-SDA-2026-04-08-gap-debate-20260406-0
Hypothesis

Compensatory Cytokine Network Activation

In AD, blocking TNF-α/IL-6 triggers compensatory upregulation of alternative inflammatory cascades (IL-1β, NLRP3) that don't exist in cardiovascular disease.
🧬 NLRP3🩺 clinical-neurology🎯 Composite 46%💱 $0.52▲4.7%active
clinical neurology
EvidencePending (0%)📖 5 cit🗣 1 debates 5 support 1 oppose
✓ All Quality Gates Passed
Mechanistic 0.50 (15%) Evidence 0.50 (15%) Novelty 0.50 (12%) Feasibility 0.50 (12%) Impact 0.00 (12%) Druggability 0.50 (10%) Safety 0.50 (8%) Competition 0.50 (6%) Data Avail. 0.50 (5%) Reproducible 0.50 (5%) KG Connect 0.60 (8%) 0.455 composite

🧪 Overview

In AD, blocking TNF-α/IL-6 triggers compensatory upregulation of alternative inflammatory cascades (IL-1β, NLRP3) that don't exist in cardiovascular disease. This creates therapeutic resistance unique to neuroinflammation.

🧬 Mechanism

🧬 Curated Mechanism Pathway

Curated pathway from expert analysis

flowchart TD
    A["Anti-Cytokine Therapy<br/>TNF-alpha IL-6 Blockade in AD"]
    B["Primary Inflammatory Cascade Reduced<br/>TNF-alpha IL-6 Signaling Attenuated"]
    C["Compensatory NLRP3 Inflammasome Upregulation<br/>Alternative Inflammatory Route"]
    D["IL-1beta IL-18 Increased<br/>NLRP3 Compensatory Activation"]
    E["Pyroptosis in Disease-Associated Microglia<br/>Cell Death and DAMP Release"]
    F["Therapeutic Resistance<br/>AD-Specific Compensatory Loops"]
    G["NLRP3 Inhibitor Co-Treatment<br/>MCC950 or Dapansutrile"]
    H["Dual Blockade Strategy<br/>TNF-alpha IL-6 Plus NLRP3"]
    I["Neuroinflammation Resolved<br/>Synapse Protection"]
    A --> B
    B --> C
    C --> D
    D --> E
    E --> F
    G --> H
    H --> I
    style C fill:#b71c1c,stroke:#ef9a9a,color:#ef9a9a
    style H fill:#1b5e20,stroke:#a5d6a7,color:#a5d6a7

⚖️ Evidence

⚖️ Evidence Matrix5 supports0 contradicts
Supports
Neuroinflammation and microglial activation in Alzheimer disease: where do we go from here?
Nat Rev Neurol2021PMID:33318676medium
Supports
NLRP3 inflammasome in neuroinflammation and central nervous system diseases.
Cell Mol Immunol2025PMID:40075143medium
Supports
Microglial CMPK2 promotes neuroinflammation and brain injury after ischemic stroke.
Cell Rep Med2024PMID:38701781medium
Supports
Ripks and Neuroinflammation.
Mol Neurobiol2024PMID:38349514medium
Supports
Inflammatory aspects of Alzheimer's disease.
Acta Neuropathol2024PMID:39196440medium
📖 Linked Papers

No linked papers recorded for this hypothesis yet.

🏥 Translation

🧬 3D Protein Structure — NLRP3

🧬 PDB 7PZC Click to expand

Experimental structure from RCSB PDB | Powered by Mol*

💉 Clinical Trials

No clinical trials data linked to this hypothesis yet.

No curated ClinVar variants loaded for this hypothesis.

Run scripts/backfill_clinvar_variants.py to fetch P/LP/VUS variants.

🔍 Search ClinVar for NLRP3 →

No DepMap CRISPR Chronos data found for NLRP3.

Run python3 scripts/backfill_hypothesis_depmap.py to populate.

🏆 Tournament

🏆 Arenas / Elo

No arena matches recorded yet. Browse Arenas →

📊 Market Indicators

7d Trend
Stable
7d Momentum
▲ 0.0%
Volatility
Medium
0.0492
Events (7d)
0
Price History
▲4.7%

💾 Resource Usage

LLM Tokens
16,574
$0.0994
Total Cost
$0.0994
Metadatasource: v1_phase_c_backfill · origin_type: debate_synthesis
sourcev1_phase_c_backfill
origin_typedebate_synthesis
_schema_version1
📊 Evidence Profile
Evidence Balance
+0%
Certainty
0%
Debates
0
Incoming
0
Outgoing
0
0 supporting 0 contradicting 0 neutral
Public annotations (0)Annotate on Hypothes.is →
No public annotations yet.